| For: | Cao BL, Qasem A, Sharp RC, Abdelli LS, Naser SA. Systematic review and meta-analysis on the association of tuberculosis in Crohn’s disease patients treated with tumor necrosis factor-α inhibitors (Anti-TNFα). World J Gastroenterol 2018; 24(25): 2764-2775 [PMID: 29991880 DOI: 10.3748/wjg.v24.i25.2764] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i25/2764.htm |
| Number | Citing Articles |
| 1 |
Brett D. M. Jones, Zafiris J. Daskalakis, Andre F. Carvalho, Rebecca Strawbridge, Allan H. Young, Benoit H. Mulsant, M. Ishrat Husain. Inflammation as a treatment target in mood disorders: review. BJPsych Open 2020; 6(4) doi: 10.1192/bjo.2020.43
|
| 2 |
Ahmad Qasem, Erij Elkamel, Saleh A. Naser. Anti-MAP Triple Therapy Supports Immunomodulatory Therapeutic Response in Crohn’s Disease through Downregulation of NF-κB Activation in the Absence of MAP Detection. Biomedicines 2020; 8(11) doi: 10.3390/biomedicines8110513
|
| 3 |
Lifan Zhang, Shijun Wan, Ziyue Zhou, Yueqiu Zhang, Xiaoqing Liu. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06351-w
|
| 4 |
Nazan Dalgic, Ayse Sahin, Selda Hancerli Torun, Ozge Kaba, Pinar Onal, Ayse Tekin Yilmaz, Ozden Turel, Belma Yasar, Manolya Kara, Deniz Aygun, Ayse Kilinc, Selim Oncel, Burcu Bursal Duramaz, Nafiye Urganci, Ayper Somer, Haluk Cokugras, Emin Sami Arisoy. Active and Latent Tuberculosis in Children Treated with Anti-TNF-α: A Retrospective Multicenter Study. Journal of Pediatric Infectious Diseases 2022; 17(02) doi: 10.1055/s-0042-1743195
|
| 5 |
|
| 6 |
María Florencia Mercogliano, Sofía Bruni, Florencia Mauro, Patricia Virginia Elizalde, Roxana Schillaci. Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy. Cancers 2021; 13(3) doi: 10.3390/cancers13030564
|
| 7 |
Laura Sanchis-Artero, Juan Francisco Martínez-Blanch, Sergio Manresa-Vera, Ernesto Cortés-Castell, Marina Valls-Gandia, Marisa Iborra, Jose Maria Paredes-Arquiola, Maia Boscá-Watts, Jose Maria Huguet, Rafael Gil-Borrás, Josefa Rodríguez-Morales, Xavier Cortés-Rizo. Evaluation of changes in intestinal microbiota in Crohn’s disease patients after anti-TNF alpha treatment. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88823-2
|
| 8 |
Xinyu Yu, Dong Liu, Xiqing Luo, Xianghui Wen, Zena Chen, Shude Chen, Budian Liu, Jinwei Li, Yuxuan Zhang, Jieruo Gu. Noncanonical Differentiation of Memory B Cells Drives Latent Tuberculosis Infection Reactivation Upon Tumor Necrosis Factor‐Alpha Inhibitor Therapy: An Integrative Transcriptomic Study. International Journal of Rheumatic Diseases 2025; 28(7) doi: 10.1111/1756-185X.70311
|
| 9 |
Ya He, Ziying Gong, Xiaokai Zhao, Daoyun Zhang, Zhongshun Zhang. Comprehensive Determination of Mycobacterium tuberculosis and Nontuberculous Mycobacteria From Targeted Capture Sequencing. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.00449
|
| 10 |
Esra’a Keewan, Shazia Beg, Saleh A. Naser. Anti-TNF-α agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.641295
|
| 11 |
Taylor J. Louis, Ahmad Qasem, Saleh A. Naser. Attenuation of Excess TNF-α Release in Crohn’s Disease by Silencing of iRHOMs 1/2 and the Restoration of TGF-β Mediated Immunosuppression Through Modulation of TACE Trafficking. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.887830
|
| 12 |
Dania AlQasrawi, Ahmad Qasem, Saleh A. Naser. Divergent Effect of Cigarette Smoke on Innate Immunity in Inflammatory Bowel Disease: A Nicotine-Infection Interaction. International Journal of Molecular Sciences 2020; 21(16) doi: 10.3390/ijms21165801
|
| 13 |
Xiuqin Mao, Aifang Zhou, Junqin Peng. Role of Neuron-Specific Enolase, D-Dimer and C-Reactive Protein in the Cranial Nerve Injury After Surgery of Posterior Fossa Tumor. Journal of Biomaterials and Tissue Engineering 2023; 13(12) doi: 10.1166/jbt.2023.3348
|
| 14 |
Germán Ramírez-Olivencia, Celia Caravaca, Marta Sanz Alba, Álvaro de la Serna Gamboa, Ignacio Díaz Villalonga. Beyond the Flare: A Case of Disseminated Tuberculosis and Thrombosis Masquerading as IBD Exacerbation. Clinical Journal of Gastroenterology 2026; 19(3) doi: 10.1007/s12328-026-02303-6
|
| 15 |
Dania AlQasrawi, Saleh A. Naser. Nicotine Modulates MyD88-Dependent Signaling Pathway in Macrophages during Mycobacterial Infection. Microorganisms 2020; 8(11) doi: 10.3390/microorganisms8111804
|
| 16 |
Giuseppe Murdaca, Simone Negrini, Marco Pellecchio, Monica Greco, Chiara Schiavi, Francesca Giusti, Francesco Puppo. Update upon the infection risk in patients receiving TNF alpha inhibitors. Expert Opinion on Drug Safety 2019; 18(3) doi: 10.1080/14740338.2019.1577817
|
| 17 |
Amna Naser, Ahmad K. Odeh, Robert C. Sharp, Ahmad Qasem, Shazia Beg, Saleh A. Naser. Polymorphisms in TNF Receptor Superfamily 1B (TNFRSF1B:rs3397) are Linked to Mycobacterium avium paratuberculosis Infection and Osteoporosis in Rheumatoid Arthritis. Microorganisms 2019; 7(12) doi: 10.3390/microorganisms7120646
|
| 18 |
George N. Okoli, Benjamin J. Cowling, Nicole Askin, Diane M. Harper, Paul Van Caeseele. Risk of active tuberculosis and herpes zoster with tumor necrosis factor inhibitor treatment in adults with autoimmune disease conditions: a systematic trial sequential analysis of randomized placebo-controlled clinical trials. Expert Opinion on Drug Safety 2026; doi: 10.1080/14740338.2026.2642872
|
| 19 |
Qin Yu Yang, Yi Juan Liu, Ye Xu, Lin Zhang, Cheng Dang Wang. Monitoring frequency of interferon gamma release assay for tuberculosis surveillance following infliximab therapy in patients with Crohn's disease. Journal of Digestive Diseases 2021; 22(8) doi: 10.1111/1751-2980.13032
|
| 20 |
Jamie L. Waldron, Stephen A. Schworer, Mildred Kwan. Hypersensitivity and Immune-related Adverse Events in Biologic Therapy. Clinical Reviews in Allergy & Immunology 2021; 62(3) doi: 10.1007/s12016-021-08879-w
|
| 21 |
Sergio Palacios-Penedo, Miguel Arias-Guillén, Patricio Escalante, Cristian Castelló-Abietar, Iván Menéndez-Valle, Gema Ramírez-Parras, Primitivo Buendía-Romero, José-María García-García, Sabino Riestra-Menéndez, Victor Asensi-Álvarez, Juan-José Palacios-Gutiérrez. Fourth-generation chemiluminescence QuantiFERON-TB Plus assay versus T-SPOT.TB semi-automated assay: a case for the use of both assays in immunosuppressed patients. ERJ Open Research 2026; 12(3) doi: 10.1183/23120541.01257-2025
|
| 22 |
Joel V. Chua, John W. Baddley. Infectious Complications in Biologic and Targeted Therapies. 2022; doi: 10.1007/978-3-031-11363-5_5
|
| 23 |
Şeyma BAŞLILAR, Mehtap AYDIN. Evaluation of long-term effect of tuberculosis chemoprophylaxis in patients using anti tumor necrosis factor alpha agents. Anatolian Current Medical Journal 2021; 3(2) doi: 10.38053/acmj.854759
|
| 24 |
Coad Thomas Dow, Leonardo A Sechi. Cows Get Crohn’s Disease and They’re Giving Us Diabetes. Microorganisms 2019; 7(10) doi: 10.3390/microorganisms7100466
|
| 25 |
Ahmad Qasem, Seela Ramesh, Saleh A Naser. Genetic polymorphisms in tumour necrosis factor receptors (TNFRSF1A/1B) illustrate differential treatment response to TNFα inhibitors in patients with Crohn’s disease. BMJ Open Gastroenterology 2019; 6(1) doi: 10.1136/bmjgast-2018-000246
|